Recall365
Recalls › Australia › CIPLA HYDROCORTISONE (as sodium succinate) 100 mg powder fo…

CIPLA HYDROCORTISONE (as sodium succinate) 100 mg powder for injection vial — recall

Health products · Australia · 2026-11-16

CIPLA HYDROCORTISONE 100 mg powder for injection vial, glass particle risk

→ See all Cipla recalls

CountryAustralia
CategoryHealth products
Published2026-11-16
BrandCIPLA
CompanyCipla Australia Pty Ltd
Batch / expiryBatch Number: HY0102501A; Expiry Date: 03/2027
Product typeMedicine
Registration no. (ARTG)373394
Recall levelRetail
Hazard classClass II
ReasonThe presence of a glass particle was reported in a vial of Hydrocortisone (as sodium succinate) 100 mg powder for injection vial. The contaminant was identified as a single glass fragment measuring approximately 8.88 × 6.13 × 1.04 mm length x width x height. The observed glass particle will not pass through the standard injection needle. Although the particle is relatively large and likely to be detected during preparation, the possibility of fragmentation into smaller particles cannot be excluded. Given the intravenous route of administration, if smaller fragments were inadvertently admini…
Recall typeRecall
RemedyAll customers are to: - Isolate and quarantine Batch HY0102501A with Expiry date: 03/2027 immediately and remove from further sale and distribution. Wholesalers are to: - Contact hospitals and/or health institutions where the affected batch was sold. Hospitals and Pharmacies are to: - Contact their wholesaler, who will provide further instructions on how to return or destroy the product and options to claim credit or resupply of product to replace affected stock.
Affected areaAustralia
Recall numberRC-2026-RN-00935-1
Official noticeView source ↗

Get alerted when Cipla has another recall

Free: we'll email you when Cipla appears in a new official recall across 11 markets, including the US, EU and Japan.

Watch Cipla recalls — free →

What this means for sellers

Likely platform / channel actionsRetailers/importers typically pull and return stock; similar products may face tighter border checks.
Self-check for comparable productsEnvironmental/batch micro testing; cold-chain records.
Rules & standards likely involvedthe destination market's product-safety rules and mandatory standards

🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →

General guidance only — not compliance or legal advice; the official notice and applicable law prevail.

Stay ahead of recalls like this

Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.

By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).

Or search & set alerts — free →

Related health products recalls